Skip to Content

Notice

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.

Project: Opioid Drugs in Maintenance and Detoxification Treatment of Opioid Dependence—42 CFR Part 8 and Opioid Treatment Programs (OTPs) (OMB No. 0930-0206)—Revision

42 CFR part 8 establishes a certification program managed by SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation requires that Opioid Treatment Programs (OTPs) be certified. “Certification” is the process by which SAMHSA determines that an OTP is qualified to provide opioid treatment under the Federal opioid treatment standards established by the Secretary of Health and Human Services. To become certified, an OTP must be accredited by a SAMHSA-approved accreditation body. The regulation also provides standards for such services as individualized treatment planning, increased medical supervision, and assessment of patient outcomes. This submission seeks continued approval of the information collection requirements in the regulation and of the forms used in implementing the regulation.

SAMHSA currently has approval for the Application for Certification to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 (Form SMA-162); the Application for Approval as Accreditation Body Under 42 CFR 8.3(b) (Form SMA-163); and the Exception Request and Record of Justification Under 42 CFR 8.12 (Form SMA-168), which may be used on a voluntary basis by physicians when there is a patient care situation in which the physician must make a treatment decision that differs from the treatment regimen required by the regulation. Form SMA-168 is a simplified, standardized form to facilitate the documentation, request, and approval process for exceptions.

SAMHSA believes that the recordkeeping requirements in the regulation are customary and usual practices within the medical and rehabilitative communities and has not calculated a response burden for them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and 8.12 include maintenance of the following: 5-year retention by accreditation bodies of certain records pertaining to accreditation; documentation by an OTP of the following: A patient's medical examination when admitted to treatment, A patient's history, a treatment plan, any prenatal support provided the patient, justification of unusually large initial doses, changes in a patient's dosage schedule, justification of unusually large daily doses, the rationale for decreasing a patient's clinic Start Printed Page 16517attendance, and documentation of physiologic dependence.

The rule also includes requirements that OTPs and accreditation organizations disclose information. For example, 42 CFR 8.12(e)(1) requires that a physician explain the facts concerning the use of opioid drug treatment to each patient. This type of disclosure is considered to be consistent with the common medical practice and is not considered an additional burden. Further, the rule requires, under Sec. 8.4(i)(1) that accreditation organizations shall make public their fee structure; this type of disclosure is standard business practice and is not considered a burden.

There are no changes being made to the forms. The reason for the reduction in burden hours is due to more respondents submitting information through an online function. The forms are available online with a unique feature for both the SMA-162 and SMA-168 that pre-populates certain information within the form. This in turn reduces the program's time spent filling out the forms as well as the staff time spent on processing it. Also, a final rule effective January 7, 2013, (77 FR 72752, Federal Register December 6, 2012) eliminated dispensing restrictions for buprenorphine products used in OTPs. As a result there OTPs will complete and submit fewer SMA-168 forms, therefore reducing burden hours.

The tables that follow summarize the annual reporting burden associated with the regulation, including burden associated with the forms.

Estimated Annual Reporting Requirement Burden for Accreditation Bodies

42 CFR citationPurposeNumber of respondentsResponses/ respondentTotal responsesHours/ responseTotal hours
8.3(b)(1-11)Initial approval (SMA-163)1116.06
8.3(c)Renewal of approval (SMA-163)2121.02
8.3(e)Relinquishment notification1110.50.5
8.3(f)(2)Non-renewal notification to accredited OTPs190900.19
8.4(b)(1)(ii)Notification to SAMHSA for seriously noncompliant OTPs2241.04
8.4(b)(1)(iii)Notification to OTP for serious noncompliance210201.020
8.4(d)(1)General documents and information to SAMHSA upon request65300.515
8.4(d)(2)Accreditation survey to SAMHSA upon request6754500.029
8.4(d)(3)List of surveys, surveyors to SAMHSA upon request66360.27.2
8.4(d)(4)Report of less than full accreditation to SAMHSA65300.515
8.4(d)(5)Summaries of Inspections6503000.5150
8.4(e)Notifications of Complaints126720.536
8.6(a)(2) and (b)(3)Revocation notification to Accredited OTPs11851850.355.5
8.6(b)Submission of 90-day corrective plan to SAMHSA1111010.0
8.6(b)(1)Notification to accredited OTPs of Probationary Status11851850.355.0
Sub Total541,407394.20

Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs

42 CFR citationPurposeNumber of respondentsResponses/ respondentTotal responsesHours/ responseTotal hours
8.11(b)Renewal of approval (SMA-162)38613860.1557.9
8.11(b)Relocation of Program (SMA-162)351351.1740.95
8.11(e)(1)Application for provisional certification42142142.00
8.11(e)(2)Application for extension of provisional certification301300.257.50
8.11(f)(5)Notification of sponsor or medical director change (SMA-162)601600.16.00
8.11(g)(2)Documentation to SAMHSA for interim maintenance11111.00
8.11(h)Request to SAMHSA for Exemption from 8.11 and 8.12 (including SMA-168)1,2002024,0000.071680
8.11(i)(1)Notification to SAMHSA Before Establishing Medication Units (SMA-162)101100.252.5
8.12(j)(2)Notification to State Health Officer When Patient Begins Interim Maintenance120200.336.6
8.24Contents of Appellant Request for Review of Suspension2120.25.50
8.25(a)Informal Review Request2121.002.00
8.26(a)Appellant's Review File and Written Statement2125.0010.00
8.28(a)Appellant's Request for Expedited Review2121.002.00
8.28(c)Appellant Review File and Written Statement2125.0010.00
Sub Total1,77524,5941868.95
Total1,82926,0012,263.15
Start Printed Page 16518

Written comments and recommendations concerning the proposed information collection should be sent by April 15, 2013 to the SAMHSA Desk Officer at the Office of Information and Regulatory Affairs, Office of Management and Budget (OMB). To ensure timely receipt of comments, and to avoid potential delays in OMB's receipt and processing of mail sent through the U.S. Postal Service, commenters are encouraged to submit their comments to OMB via email to: OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send their comments via email, commenters may also fax their comments to: 202-395-7285. Commenters may also mail them to: Office of Management and Budget, Office of Information and Regulatory Affairs, New Executive Office Building, Room 10102, Washington, DC 20503.

Start Signature

Summer King,

Statistician.

End Signature End Preamble

[FR Doc. 2013-06029 Filed 3-14-13; 8:45 am]

BILLING CODE 4162-20-P